Introduction:
In a significant legal development, the Judicial First Class Magistrate-II of Palakkad, Kerala, has issued non-bailable warrants against yoga guru Baba Ramdev and Acharya Balkrishna, co-founders of Patanjali Ayurved, following their repeated non-appearance in a criminal case filed by the Kerala Drugs Inspector. The case centres on allegations that Divya Pharmacy, an affiliate of Patanjali Ayurved, disseminated misleading medical advertisements in English and Malayalam newspapers, contravening the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Background of the Case:
The legal proceedings were initiated in October 2024 when the Kerala Drugs Inspector filed a complaint against Divya Pharmacy, Baba Ramdev, and Acharya Balkrishna. The complaint alleges violations of Sections 3, 3(b), and 3(d) of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Specifically, Section 3 prohibits advertisements of certain drugs for the treatment of specific diseases and disorders; Section 3(b) forbids advertisements claiming to enhance sexual pleasure; and Section 3(d) bans advertisements asserting the diagnosis, cure, mitigation, treatment, or prevention of diseases as specified under the Act.
The accused were initially summoned to appear in court on January 16, 2025. Upon their failure to attend, the court issued bailable warrants, mandating their appearance on February 1, 2025. Their continued absence led the court to escalate the matter by issuing non-bailable warrants to ensure their presence at the next hearing scheduled for February 15, 2025.
Prosecution’s Standpoint:
The prosecution, led by the Kerala Drugs Inspector, contends that Divya Pharmacy published advertisements making unsubstantiated claims about their products’ efficacy in treating ailments such as high blood pressure and diabetes. These actions are alleged to be in direct violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. The prosecution emphasizes that such advertisements not only mislead consumers but also pose significant public health risks by promoting unverified treatments.
Defence’s Perspective:
As of now, Baba Ramdev, Acharya Balkrishna, and Divya Pharmacy have not publicly responded to the recent court actions. Historically, Patanjali Ayurved has maintained that its products are based on traditional Ayurvedic knowledge and have been developed following necessary regulatory approvals. In previous legal challenges, the company has argued that its advertisements are within legal frameworks and aim to promote alternative medicine systems. However, their non-appearance in court has led to increased legal scrutiny and the issuance of non-bailable warrants.
Court’s Decision:
The Judicial First Class Magistrate-II of Palakkad, observing the absence of the accused despite prior summons and bailable warrants, issued non-bailable warrants against Baba Ramdev and Acharya Balkrishna. The court’s decision underscores the seriousness of the allegations and the importance of the accused’s presence to address the charges. The next hearing is set for February 15, 2025, where the court expects the accused to appear and respond to the allegations.
Conclusion:
The issuance of non-bailable warrants against prominent figures like Baba Ramdev and Acharya Balkrishna highlights the judiciary’s commitment to addressing allegations of misleading medical advertisements. This case serves as a reminder of the legal obligations companies have in promoting their products and the potential consequences of non-compliance. The upcoming hearing on February 15, 2025, will be pivotal in determining the course of this case and its implications for advertising practices in the health-care sector.